🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the proportion of patients with an urticaria control test \[UCT\] ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-04-22
Trial ID
NCT02550106
Treatments Being Tested
This research is being done to study the effects of the drug omalizumab (Xo...
Status
Completed
Location
Johns Hopkins Asthma and Allergy Center
Start Date
2007-07
Trial ID
NCT00604786
Treatments Being Tested
The study is a Phase II, dose-ranging, multicenter, randomized, double-blin...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00866788
Treatments Being Tested
This will be a randomized, double blind, three-arm, single dose, parallel g...
Status
Completed
Location
Registered BABE centre
Start Date
2022-07-07
Trial ID
NCT05413161
Treatments Being Tested
This study will assess the efficacy, safety and tolerability of omalizumab,...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-09
Trial ID
NCT01202903
Treatments Being Tested
Aim: The aim of this study was to investigate the effect of subcutaneous in...
Status
Completed
Location
University of Health Sciences
Start Date
2018-06-05
Trial ID
NCT04210323
Treatments Being Tested
A Phase 1, Randomized, Double-blind, Three-arm, Parallel Group, Single-dose...
Status
Completed
Location
Phase 1 unit
Start Date
2020-05-28
Trial ID
NCT04018313
Treatments Being Tested
A single dose, double blind comparative trial to assess the pharmacokinetic...
Status
Completed
Location
Q-Pharm Pty Ltd
Start Date
2022-02-16
Trial ID
NCT05053334
Treatments Being Tested
A substance called immunoglobulin E (IgE), which is naturally produced by o...
Status
Completed
Location
Alabama Allergy and Asthma Center
Start Date
2004-04
Trial ID
NCT00079937
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of omaliz...
Status
Completed
Location
Jonathan Corren MD, Inc.
Start Date
2017-11-15
Trial ID
NCT03280550
Treatments Being Tested